• First in-vivo gene replacement therapy program for MSUD
• MSUD is a severe genetic disease with liver transplantation as the only treatment currently available
• Transformational in-vivo AAV gene therapy for hemophilia A
• Efficiently biosynthesized and secreted bioengineered factor VIII
• Potentially leads to lower vector dose, reduced cost and extende......